In the rapidly evolving landscape of healthcare, genetic testing is emerging as a pivotal force, promising to transform patient care through precision medicine. The insights derived from our genetic codes hold the potential to not only prevent diseases but also optimize treatments and promote healthier living. Yet, as highlighted in a recent MedCity News article, the journey towards realizing this potential is fraught with challenges, particularly around patient privacy and data sharing.
The Role of Information Technology
A critical component in addressing these challenges is information technology security. Organizations are turning to certifications like HITRUST to establish standards for safeguarding sensitive information. By aligning with these standards, they can protect data while facilitating the sharing necessary to enhance medical knowledge and patient care.
Collaborative Efforts and Data Sharing
Collaboration is at the heart of advancing genetic testing. Companies are contributing de-identified variant data to public health databases such as ClinVAR and the SEER Cancer Registries. These efforts, supported by cancer research registries, deepen insights and expedite advancements in patient care.
The analysis of expansive data sets is crucial for understanding diseases, allowing researchers to access, assess, and test hypotheses. This collaborative approach is paving the way for tailored treatment plans and new biological discoveries, enhancing early disease detection and intervention.
Integration with Electronic Health Records
Integrating genetic testing with Electronic Health Records (EHR) is another key strategy for improving patient outcomes. Collaborations with EHR vendors like Epic, Flatiron, and Athena streamline processes, making it easier for providers to order genetic products, optimize screening protocols, and identify potential pharmacogenetic interactions. Such collaborations break down silos, enhancing data exchange for more effective research and patient care.
Challenges and Future Trends
Despite the promising progress, the integration of genetic testing into mainstream medicine presents challenges, including managing the vast volume of genomic data. Companies are focusing on presenting complex clinical interpretations, integrating common data ontologies, overcoming data fragmentation, and ensuring data privacy to address these hurdles.
Looking ahead, the industry anticipates significant advancements, with trends like developing tests for early cancer recurrence detection and embracing a multi-omics approach that integrates RNA, proteins, and AI insights. The integration of generative AI for documentation and genetic counseling is another notable development on the horizon.
A New Era in Healthcare
Genetic testing represents more than just a scientific advancement; it signifies a fundamental shift in how we approach health and wellness. As public understanding grows and technology advances, we find ourselves at the dawn of a new era in healthcare, where our genetic code becomes a roadmap to better health and longevity.
About the Author
Kevin Haas, Ph.D., serves as the Chief Technology Officer at Myriad Genetics, where he leads the development of the precision medicine platform. With expertise in molecular simulation and machine learning, Haas is advancing genomics and digital patient/provider experiences. He has co-authored 16 peer-reviewed publications and nine patent applications, bringing a wealth of experience to his role.
More Articles
Getting licensed or staying ahead in your career can be a journey—but it doesn’t have to be overwhelming. Grab your favorite coffee or tea, take a moment to relax, and browse through our articles. Whether you’re just starting out or renewing your expertise, we’ve got tips, insights, and advice to keep you moving forward. Here’s to your success—one sip and one step at a time!
Local elections across major U.S. cities have kicked off a wave of policy changes that could reshape development costs, rental income, and investment strategies heading into 2026. From NYC’s aggressive tenant‑protection agenda to Chicago’s sustainability push, Miami’s political uncertainty, and Boston’s steady zoning overhaul, the post‑election environment is redefining how real estate professionals, investors, and lenders should prepare for the year ahead.
Insurance carriers are rapidly rolling out AI-related exclusions that strip coverage from claims involving AI tools, automated decision‑making, or generative platforms like ChatGPT and Midjourney. With firms like Berkley and Hamilton introducing sweeping “absolute” and generative‑AI‑specific exclusions, professionals in real estate, mortgage, insurance, and finance now face new liability gaps. As AI becomes unavoidable in everyday work, understanding these exclusions is essential for protecting your career and staying compliant in a fast‑changing risk environment.
Proptech startup Venn has raised a $52 million Series B to unify the entire renting lifecycle into one intelligent platform, replacing over a dozen traditional systems and serving more than half a million tenants. As AI‑powered tools like Venn rapidly reshape property operations, real estate professionals — especially in fast‑moving markets like Florida — will need stronger education and tech‑savvy skills to stay competitive.
Florida’s Gulf Coast is undergoing a dramatic transformation as soaring insurance premiums, costly construction requirements, and the long shadow of Hurricane Ian force middle‑class families, workers, and longtime residents out of communities they once anchored. With premiums topping $5,700 a year — and many paying far more — Realtors warn of looming foreclosures, renters face steep increases, and entire neighborhoods are being rebuilt for wealthier newcomers. This mounting crisis is reshaping the state’s real estate landscape and leaving professionals scrambling to adapt.
Economic uncertainty, rapid tech advances and shifting population patterns are setting the stage for a pivotal year in commercial real estate. New findings from the Counselors of Real Estate, presented at NAR NXT, outline ten major forces reshaping strategy, investment and opportunity in 2026—from policy impacts and portfolio risk to AI adoption, capital flow changes, housing attainability and demographic shifts. This outlook offers clarity and caution for professionals across real estate, mortgage, finance and related fields.
Florida’s home insurance crisis is back in the spotlight as new reforms appear to be repeating decades‑old mistakes. Despite efforts to depopulate Citizens and attract private insurers, many of the companies taking over policies have ties to past insolvencies. Critics say weak oversight, generous ratings, and political influence are allowing unstable insurers to thrive while homeowners pay more for less protection. Experts warn that without transparent ratings, real accountability, and unified regulation, Florida’s insurance market will remain vulnerable—putting property values, lending, and the broader real estate industry at risk.
